primary hepatic carcinoma
Conditions
Interventions
Experimental group:Fluorescent laparoscopic hepatectomy
Sponsors
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Preoperative clinical or pathological diagnosis of primary liver cancer; 2. Patients identified by the investigator as meeting the indications for laparoscopic hepatectomy; 3. No local treatment such as intervention and radiofrequency ablation has been received; 4. Patients and their families can understand and are willing to participate in this clinical study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Contraindications for laparoscopic hepatectomy were determined by researchers; 2. Allergic to ICG or iodine; 3. Patients with recurrent liver tumor; 4. Patients who have participated in or are participating in other clinical trials within 4 weeks prior to enrollment; 5. Have a history of serious mental illness; History of other malignant tumors in the past 5 years; 6. Pregnant or lactating patients; 7. Patients with other conditions considered by the investigator/should not be enrolled in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between preoperative indocyanine green injection time and concentration in patients with cirrhosis with different degrees of tumor staining;Relationship between the nature of postoperative pathological lesions and the type of intraoperative fluorescence imaging;Success rate of target lesion development (tumor development type, microhepatocellular carcinoma mapping rate);The accuracy of intraoperative fluorescence quantitative assessment of liver cirrhosis;Success rate of target segment liver mapped;Safety (incidence of intraoperative bile leakage, incidence of postoperative bile leakage); | — |
Countries
China
Contacts
Public ContactChen Yajin
Outcome results
None listed